Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
WAYNE, Pa., May 07, 2024 -- Teleflex Incorporated , a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American Urological Association...